154 matching assessments
| ARC | 2+ Digits Required | |
| NAICS | 3+ Digits Required | |
| SIC | Pharmaceutical preparations | |
| 3+ Characters Required for Products | ||
| ID | Year | Products | Recommendations Rec's | Plant Energy Costs Per Year $/yr | Recommended Rec'd Savings Per Year Savings $/yr |
|---|---|---|---|---|---|
| UF0627 | 2025 | Encapsulated pills and active pharmaceutical ingredients | 8 | $372k | $98k |
| UC2502 | 2025 | Pharmaceutical drugs | 7 | $828k | $108k |
| UC2501 | 2025 | Pharmaceutical skin care product | 11 | $301k | $101k |
| SF0628 | 2024 | Synthetic peptides | 3 | $604k | $75k |
| SF0623 | 2024 | Synthetic peptides | 5 | $186k | $16k |
| MI0445 | 2024 | Pharmaceuticals | 8 | $3,373k | $837k |
| MI0443 | 2024 | Soft gels | 8 | $376k | $65k |
| MI0439 | 2024 | Pharmaceuticals | 6 | $1,040k | $662k |
| SU0551 | 2024 | Biologics drug substance | 11 | $2,735k | $116k |
| SU0548 | 2024 | Biologics drug substance | 10 | $2,278k | $217k |
| UW2402 | 2024 | Pharmaceutical preparation manufacturing | 8 | $396k | $177k |
| MI0436 | 2023 | Vitamins, supplements | 9 | $221k | $3,202k |
| OR0779 | 2023 | Phase i/ii clinical trial materials, spray-dried drugs, tablets/capsules | 4 | $107k | $54k |
| LE0546 | 2023 | Generic drugs | 9 | $2,388k | $170k |
| CC0011 | 2022 | Active pharmaceutical ingredients | 5 | $549k | $20k |
| UD1038 | 2022 | Pharmaceuticals | 7 | $1,084k | $91k |
| MI0395 | 2021 | Pharma tablets | 7 | $579k | $54k |
| NL0061 | 2021 | Otc medicine | 8 | $1,706k | $34k |
| NC0654 | 2020 | Pharmaceutical preparations | 5 | $4,501k | $1,454k |
| UD1024 | 2020 | Vivitrol, aristada, risperdal consta, and polymer | 11 | $1,940k | $1,139k |